{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:13:27Z","timestamp":1787436807971,"version":"build-2736575974"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Jilin Provincial Department of Education","award":["JJKH20221067KJ"],"award-info":[{"award-number":["JJKH20221067KJ"]}]},{"name":"Project of Jilin Provincial Department of Education","award":["JJKH20221067KJ"],"award-info":[{"award-number":["JJKH20221067KJ"]}]},{"name":"Project of Jilin Provincial Department of Education","award":["JJKH20221067KJ"],"award-info":[{"award-number":["JJKH20221067KJ"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01565-7","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:13:19Z","timestamp":1738764799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of CD4+ T cell-derived cytokines in the pathogenesis of uveitis"],"prefix":"10.1007","volume":"25","author":[{"given":"Tingting","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3083-8906","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"3","key":"1565_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.pop.2015.05.003","volume":"42","author":"JP Dunn","year":"2015","unstructured":"Dunn JP. Uveitis. Primary Care Clin Off Prac. 2015;42(3):305\u201323. https:\/\/doi.org\/10.1016\/j.pop.2015.05.003.","journal-title":"Primary Care Clin Off Prac"},{"issue":"5","key":"1565_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5301\/ejo.5000278","volume":"23","author":"E Miserocchi","year":"2013","unstructured":"Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705\u201317.","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"1565_CR3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/02713680500263606","volume":"30","author":"P Yang","year":"2005","unstructured":"Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30(11):943\u20138.","journal-title":"Curr Eye Res"},{"issue":"12","key":"1565_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","volume":"16","author":"P S\u00e8ve","year":"2017","unstructured":"S\u00e8ve P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, et al. Uveitis: diagnostic work-up. a literature review and recommendations from an expert committee. Autoimmun Rev. 2017;16(12):1254\u201364. https:\/\/doi.org\/10.1016\/j.autrev.2017.10.010.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1565_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41435-022-00168-6","volume":"23","author":"XF Huang","year":"2022","unstructured":"Huang XF, Brown MA. Progress in the genetics of uveitis. Genes Immun. 2022;23(2):57\u201365.","journal-title":"Genes Immun"},{"key":"1565_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02339-z","author":"F Saeedi","year":"2024","unstructured":"Saeedi F, Salehi M, Kamali MJ, Mir MA, Kazemi S, Shirafkan F, et al. Evaluation of the cytotoxic activities of the essential oil from Pistacia Atlantica Desf. oleoresin on human gastric cancer cell lines. Med Oncol. 2024. https:\/\/doi.org\/10.1007\/s12032-024-02339-z.","journal-title":"Med Oncol"},{"issue":"12","key":"1565_CR7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/00914037.2020.1765357","volume":"70","author":"A Ghamkhari","year":"2021","unstructured":"Ghamkhari A, Abbasi F, Abbasi E, Ghorbani M. A novel thermo-responsive system based on \u03b2-cyclodextrin-nanocomposite for improving the docetaxel activity. Int J Polym Mater Polym Biomater. 2021;70(12):830\u201340.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"1565_CR8","doi-asserted-by":"crossref","unstructured":"Lee RW, Nicholson LB, Sen HN, Chan C-C, Wei L, Nussenblatt RB, et al., editors. Autoimmune and autoinflammatory mechanisms in uveitis. Seminars in immunopathology; 2014: Springer.","DOI":"10.1007\/s00281-014-0433-9"},{"key":"1565_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10238-015-0345-6","volume":"16","author":"M Prete","year":"2016","unstructured":"Prete M, Dammacco R, Fatone MC, Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2016;16:125\u201336.","journal-title":"Clin Exp Med"},{"key":"1565_CR10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623725","volume":"12","author":"CE Egwuagu","year":"2021","unstructured":"Egwuagu CE, Alhakeem SA, Mbanefo EC. Uveitis: molecular pathogenesis and emerging therapies. Front Immunol. 2021;12: 623725.","journal-title":"Front Immunol"},{"key":"1565_CR11","doi-asserted-by":"crossref","first-page":"1178792","DOI":"10.3389\/fimmu.2023.1178792","volume":"14","author":"J Qi","year":"2023","unstructured":"Qi J, Liu C, Bai Z, Li X, Yao G. T follicular helper cells and T follicular regulatory cells in autoimmune diseases. Front Immunol. 2023;14:1178792.","journal-title":"Front Immunol"},{"key":"1565_CR12","doi-asserted-by":"crossref","unstructured":"Shoarishoar SS, Milani F, Adineh S, Sorouri ZR, Attari SM. Comparison of pregnancy outcomes in amniocentesis recipients with normal and abnormal maternal serum analytes. Cellular and molecular biology (Noisy-le-Grand, France). 2024;70(11):109\u201314.","DOI":"10.14715\/cmb\/2024.70.11.16"},{"issue":"3","key":"1565_CR13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/cmi.2010.24","volume":"7","author":"RI Nurieva","year":"2010","unstructured":"Nurieva RI, Chung Y. Understanding the development and function of T follicular helper cells. Cell Mol Immunol. 2010;7(3):190\u20137.","journal-title":"Cell Mol Immunol"},{"key":"1565_CR14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","volume":"9","author":"N Gensous","year":"2018","unstructured":"Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet M-E, Lazaro E, et al. T follicular helper cells in autoimmune disorders. Front Immunol. 2018;9:1637.","journal-title":"Front Immunol"},{"issue":"1","key":"1565_CR15","doi-asserted-by":"crossref","first-page":"2058964","DOI":"10.1155\/2021\/2058964","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ge R, Chen H, Ahiafor M, Liu B, Chen J, et al. Follicular helper CD4+ T cells, follicular regulatory CD4+ T cells, and inducible costimulator and their roles in multiple sclerosis and experimental autoimmune encephalomyelitis. Mediators Inflamm. 2021;2021(1):2058964.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1565_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5\u201317.","journal-title":"Cytokine"},{"issue":"3","key":"1565_CR17","first-page":"223","volume":"8","author":"P Kidd","year":"2003","unstructured":"Kidd P. Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223\u201346.","journal-title":"Altern Med Rev"},{"key":"1565_CR18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s10753-015-0167-4","volume":"38","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhou J, Fu S, Wang C, Zhou B. A study of association between oral lichen planus and immune balance of Th1\/Th2 cells. Inflammation. 2015;38:1874\u20139.","journal-title":"Inflammation"},{"issue":"10","key":"1565_CR19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discovery. 2012;11(10):763\u201376.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"1565_CR20","first-page":"17","volume":"27","author":"A Owczarczyk-Saczonek","year":"2018","unstructured":"Owczarczyk-Saczonek A, Czerwi\u0144ska J, Placek W. The role of regulatory T cells and anti-inflammatory cytokines in psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27(1):17\u201323.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"1565_CR21","doi-asserted-by":"crossref","unstructured":"Shoarishoar SS, KaboodMehri R, Fakor F, Sorouri ZR, Mansour-Ghanaei M, Darkhaneh RF, et al. Assessment of decreased ovarian reserve and systemic inflammatory markers. Cellular and molecular biology (Noisy-le-Grand, France). 2024;70(11):144-9.","DOI":"10.14715\/cmb\/2024.70.11.21"},{"key":"1565_CR22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10753-016-0470-8","volume":"40","author":"J-H Tao","year":"2017","unstructured":"Tao J-H, Cheng M, Tang J-P, Liu Q, Pan F, Li X-P. Foxp3, regulatory T cell, and autoimmune diseases. Inflammation. 2017;40:328\u201339.","journal-title":"Inflammation"},{"key":"1565_CR23","volume":"114","author":"M Zhang","year":"2023","unstructured":"Zhang M, Zhang X. T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches. Int Immunopharmacol. 2023;114: 109565.","journal-title":"Int Immunopharmacol"},{"issue":"17","key":"1565_CR24","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.3390\/ijms22179584","volume":"22","author":"Y-H Chen","year":"2021","unstructured":"Chen Y-H, Lightman S, Calder VL. CD4+ T-cell plasticity in non-infectious retinal inflammatory disease. Int J Mol Sci. 2021;22(17):9584.","journal-title":"Int J Mol Sci"},{"key":"1565_CR25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155458","volume":"145","author":"P Chauhan","year":"2021","unstructured":"Chauhan P, Nair A, Patidar A, Dandapat J, Sarkar A, Saha B. A primer on cytokines. Cytokine. 2021;145: 155458.","journal-title":"Cytokine"},{"issue":"3\u20134","key":"1565_CR26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cyto.2006.08.003","volume":"35","author":"V Menezo","year":"2006","unstructured":"Menezo V, Bond SK, Towler HM, Kuo N-W, Baharlo B, Wilson AG, et al. Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine. 2006;35(3\u20134):200\u20136.","journal-title":"Cytokine"},{"issue":"2","key":"1565_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1167\/iovs.02-0498","volume":"44","author":"H Yamagami","year":"2003","unstructured":"Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K. The effects of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci. 2003;44(2):514\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1565_CR28","first-page":"6693542","volume":"2021","author":"K Guo","year":"2021","unstructured":"Guo K, Zhang X. Cytokines that modulate the differentiation of Th17 cells in autoimmune uveitis. J Immunol Res. 2021;2021(1):6693542.","journal-title":"J Immunol Res"},{"issue":"3","key":"1565_CR29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A","volume":"49","author":"JD Luna","year":"1997","unstructured":"Luna JD, Chan CC, Derevjanik NL, Mahlow J, Chiu C, Peng B, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor \u03b1, and interleukin-1\u03b2-mediated breakdown. J Neurosci Res. 1997;49(3):268\u201380.","journal-title":"J Neurosci Res"},{"issue":"1","key":"1565_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/0301-4738.126187","volume":"62","author":"R Agrawal","year":"2014","unstructured":"Agrawal R, Iyer J, Connolly J, Iwata D, Teoh S. Cytokines and biologics in non-infectious autoimmune uveitis: bench to bedside. Indian J Ophthalmol. 2014;62(1):74\u201381.","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"1565_CR31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/bjo.78.12.917","volume":"78","author":"O Nishi","year":"1994","unstructured":"Nishi O, Nishi K, Ohmoto Y. Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation. Br J Ophthalmol. 1994;78(12):917\u201320.","journal-title":"Br J Ophthalmol"},{"key":"1565_CR32","doi-asserted-by":"crossref","unstructured":"MO J-S, Matsukawa A, Ohkawara S, Yoshinaga M. Involvement of TNF \u03b1, IL-1\u03b2 and IL-1 receptor antagonist in LPS-induced rabbit uveitis. Experimental eye research. 1998;66(5):547\u201357.","DOI":"10.1006\/exer.1997.0451"},{"key":"1565_CR33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","volume":"9","author":"IS Junttila","year":"2018","unstructured":"Junttila IS. Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol. 2018;9:888.","journal-title":"Front Immunol"},{"key":"1565_CR34","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-71","author":"AD Keegan","year":"2021","unstructured":"Keegan AD, Leonard WJ, Zhu J. Recent advances in understanding the role of IL-4 signaling. Faculty Rev. 2021. https:\/\/doi.org\/10.12703\/r\/10-71.","journal-title":"Faculty Rev"},{"issue":"8","key":"1565_CR35","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N","volume":"28","author":"W Hu","year":"1998","unstructured":"Hu W, Hasan A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336\u2013351. Eur J Immunol. 1998;28(8):2444\u201355.","journal-title":"Eur J Immunol"},{"issue":"4","key":"1565_CR36","first-page":"659","volume":"8","author":"L-F Yuan","year":"2015","unstructured":"Yuan L-F, Li G-D, Ren X-J, Nian H, Li X-R, Zhang X-M. Rapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1\/Th2\/Th17 cells and upregulating CD4+ CD25+ Foxp3 regulatory T cells. Int J Ophthalmol. 2015;8(4):659.","journal-title":"Int J Ophthalmol"},{"issue":"9","key":"1565_CR37","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.3390\/ijms21093261","volume":"21","author":"S-M Hsu","year":"2020","unstructured":"Hsu S-M, Yang C-H, Teng Y-T, Tsai H-Y, Lin C-Y, Lin C-J, et al. Suppression of the reactive oxygen response alleviates experimental autoimmune uveitis in mice. Int J Mol Sci. 2020;21(9):3261.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1565_CR38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","volume":"142","author":"JK Ahn","year":"2006","unstructured":"Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Beh\u00e7et uveitis. Am J Ophthalmol. 2006;142(3):429-34.e1.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1565_CR39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archopht.118.6.768","volume":"118","author":"MS Lacomba","year":"2000","unstructured":"Lacomba MS, Martin CM, Chamond RR, Galera JMG, Omar M, Estevez EC. Aqueous and serum interferon \u03b3, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol. 2000;118(6):768\u201372.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1565_CR40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/1566524015666150731100012","volume":"15","author":"W Chen","year":"2015","unstructured":"Chen W, Zhao B, Jiang R, Zhang R, Wang Y, Wu H, et al. Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Curr Mol Med. 2015;15(6):543\u20139.","journal-title":"Curr Mol Med"},{"issue":"1","key":"1565_CR41","volume":"17","author":"M-H Errera","year":"2022","unstructured":"Errera M-H, Pratas A, Fisson S, Manicom T, Boubaya M, Sedira N, et al. Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitis. PLoS ONE. 2022;17(1): e0254972.","journal-title":"PLoS ONE"},{"key":"1565_CR42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2020.00358","volume":"11","author":"M Bonacini","year":"2020","unstructured":"Bonacini M, Soriano A, Cimino L, De Simone L, Bolletta E, Gozzi F, et al. Cytokine profiling in aqueous humor samples from patients with non-infectious uveitis associated with systemic inflammatory diseases. Front Immunol. 2020;11:358.","journal-title":"Front Immunol"},{"issue":"4","key":"1565_CR43","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1080\/02648725.2023.2211456","volume":"40","author":"Z Wu","year":"2024","unstructured":"Wu Z, Hou X, Qin T. Changes of peripheral blood Th cytokines in acute anterior uveitis and their relationships with recurrence. Biotechnol Genet Eng Rev. 2024;40(4):4434\u201345.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"8","key":"1565_CR44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","volume":"30","author":"BC Aridogan","year":"2003","unstructured":"Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S. Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et\u2019s disease. J Dermatol. 2003;30(8):602\u20137.","journal-title":"J Dermatol"},{"issue":"1","key":"1565_CR45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09273948.2016.1277247","volume":"26","author":"H Ghasemi","year":"2018","unstructured":"Ghasemi H. Roles of IL-6 in ocular inflammation: a review. Ocul Immunol Inflamm. 2018;26(1):37\u201350.","journal-title":"Ocul Immunol Inflamm"},{"key":"1565_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-019-0182-y","author":"S Karkhur","year":"2019","unstructured":"Karkhur S, Hasanreisoglu M, Vigil E, Halim MS, Hassan M, Plaza C, et al. Interleukin-6 inhibition in the management of non-infectious uveitis and beyond. J Ophthalm Inflamm Infect. 2019. https:\/\/doi.org\/10.1186\/s12348-019-0182-y.","journal-title":"J Ophthalm Inflamm Infect"},{"key":"1565_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155654","volume":"146","author":"T Korn","year":"2021","unstructured":"Korn T, Hiltensperger M. Role of IL-6 in the commitment of T cell subsets. Cytokine. 2021;146: 155654.","journal-title":"Cytokine"},{"issue":"6","key":"1565_CR48","first-page":"589","volume":"19","author":"M Atabaki","year":"2020","unstructured":"Atabaki M, Shariati-Sarabi Z, Barati M, Tavakkol-Afshari J, Mohammadi M. MicroRNAs as the important regulators of T helper 17 cells: a narrative review. Iran J Allergy Asthma Immunol. 2020;19(6):589\u2013601.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1565_CR49","doi-asserted-by":"crossref","unstructured":"Tuo J, Tuaillon N, Shen D, Chan C-CJIo, science v. Endotoxin-induced uveitis in cyclooxygenase-2\u2013deficient mice. 2004;45(7):2306\u201313.","DOI":"10.1167\/iovs.03-0756"},{"key":"1565_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2017.02.023","volume":"96","author":"J Tode","year":"2017","unstructured":"Tode J, Richert E, Koinzer S, Klettner A, Pickhinke U, Garbers C, et al. Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice. Cytokine. 2017;96:8\u201315. https:\/\/doi.org\/10.1016\/j.cyto.2017.02.023.","journal-title":"Cytokine"},{"key":"1565_CR51","doi-asserted-by":"crossref","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto TJNRR. Translating IL-6 biology into effective treatments. 2020;16(6):335\u201345.","DOI":"10.1038\/s41584-020-0419-z"},{"issue":"10","key":"1565_CR52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.autrev.2017.08.002","volume":"16","author":"M Mesquida","year":"2017","unstructured":"Mesquida M, Molins B, Lloren\u00e7 V, de la Maza MS, Ad\u00e1n A. Targeting interleukin-6 in autoimmune uveitis. Autoimmun Rev. 2017;16(10):1079\u201389.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1565_CR53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cei.12295","volume":"176","author":"M Mesquida","year":"2014","unstructured":"Mesquida M, Leszczynska A, Lloren\u00e7 V, Ad\u00e1n A. Interleukin-6 blockade in ocular inflammatory diseases. Clin Exp Immunol. 2014;176(3):301\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1565_CR54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-019-0182-y","volume":"9","author":"S Karkhur","year":"2019","unstructured":"Karkhur S, Hasanreisoglu M, Vigil E, Halim MS, Hassan M, Plaza C, et al. Interleukin-6 inhibition in the management of non-infectious uveitis and beyond. J Ophthalmic Inflamm Infect. 2019;9(1):17.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"1565_CR55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12348-024-00441-x","volume":"14","author":"K H\u00f6sel","year":"2024","unstructured":"H\u00f6sel K, Chasan B, Tode J, Rose-John S, Roider JB, Ehlken C. Effect of intravitreal injection of anti-interleukin (IL)-6 antibody in experimental autoimmune uveitis in mice. J Ophthalmic Inflam Infect. 2024;14(1):57.","journal-title":"J Ophthalmic Inflam Infect"},{"issue":"5","key":"1565_CR56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo RC, Garcia CC, Teixeira MM, Amaral FA. The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593\u2013619.","journal-title":"Expert Rev Clin Immunol"},{"key":"1565_CR57","doi-asserted-by":"crossref","unstructured":"Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZMJOi, inflammation. Roles of IL-8 in ocular inflammations: a review. 2011;19(6):401\u201312.","DOI":"10.3109\/09273948.2011.618902"},{"issue":"5","key":"1565_CR58","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10637-013-0005-1","volume":"31","author":"L Lattanzio","year":"2013","unstructured":"Lattanzio L, Tonissi F, Torta I, Gianello L, Russi E, Milano G, et al. Role of IL-8 induced angiogenesis in uveal melanoma. Invest New Drugs. 2013;31(5):1107\u201314. https:\/\/doi.org\/10.1007\/s10637-013-0005-1.","journal-title":"Invest New Drugs"},{"key":"1565_CR59","doi-asserted-by":"crossref","unstructured":"Vos AD, Hoekzema R, Kijlstra AJCer. Cytokines and uveitis, a review. 1992;11(6):581-97.","DOI":"10.3109\/02713689209001814"},{"issue":"12","key":"1565_CR60","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1479","volume":"12","author":"LB Ferreira","year":"2023","unstructured":"Ferreira LB, Williams KA, Best G, Haydinger CD, Smith JR. Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis. Clin Transl Immunology. 2023;12(12): e1479.","journal-title":"Clin Transl Immunology"},{"key":"1565_CR61","first-page":"2003","volume":"17","author":"NV Valentincic","year":"2011","unstructured":"Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis. 2011;17:2003\u201310.","journal-title":"Mol Vis"},{"issue":"12","key":"1565_CR62","first-page":"3376","volume":"34","author":"J De Boer","year":"1993","unstructured":"De Boer J, Hack C, Verhoeven A, Baarsma G, De Jong P, Rademakers A, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1993;34(12):3376\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1565_CR63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/09273949509085033","volume":"3","author":"K Sagawa","year":"1995","unstructured":"Sagawa K, Itoh K, Sakaguchi M, Tamai M, Sugita S, Mukaida N, et al. Production of IL-8 and the other cytokines by T cell clones established from the ocular fluid of patients with Beh\u00e7et\u2019s disease. Ocul Immunol Inflamm. 1995;3(2):63\u201372.","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"1565_CR64","doi-asserted-by":"publisher","first-page":"e45562","DOI":"10.1371\/journal.pone.0045562","volume":"7","author":"J Dwyer","year":"2012","unstructured":"Dwyer J, Hebda JK, Le Guelte A, Galan-Moya E-M, Smith SS, Azzi S, et al. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS ONE. 2012;7(9):e45562. https:\/\/doi.org\/10.1371\/journal.pone.0045562.","journal-title":"PLoS ONE"},{"issue":"4","key":"1565_CR65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09273949409057080","volume":"2","author":"L Akduman","year":"1994","unstructured":"Akduman L, Kaplan HJ, Ataoglu O, Or M, Bilgihan A, Hasanreisoglu B. Comparison of uveitis induced by interleukin-8 (IL-8) and endotoxin in rabbits. Ocul Immunol Inflamm. 1994;2(4):223\u20139.","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"1565_CR66","first-page":"2465","volume":"40","author":"MJ Verma","year":"1999","unstructured":"Verma MJ, Mukaida N, Vollmer-Conna U, Matsushima K, Lloyd A, Wakefield D. Endotoxin-induced uveitis is partially inhibited by anti\u2013IL-8 antibody treatment. Invest Ophthalmol Vis Sci. 1999;40(11):2465\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1565_CR67","doi-asserted-by":"crossref","unstructured":"MO J-S, Matsukawa A, Ohkawara S, Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Experimental eye research. 1999;68(3):333-40.","DOI":"10.1006\/exer.1998.0618"},{"key":"1565_CR68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.intimp.2018.10.040","volume":"66","author":"H Li","year":"2019","unstructured":"Li H, Zhang J, Lin L, Xu L. Vascular protection of DPP-4 inhibitors in retinal endothelial cells in in vitro culture. Int Immunopharmacol. 2019;66:162\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"1565_CR69","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7150\/ijbs.6996","volume":"9","author":"H Yu","year":"2013","unstructured":"Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T, et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci. 2013;9(9):966.","journal-title":"Int J Biol Sci"},{"key":"1565_CR70","doi-asserted-by":"crossref","unstructured":"Ooi KG-J, Galatowicz G, Calder VL, Lightman SLJCm, research. Cytokines and chemokines in uveitis\u2013Is there a correlation with clinical phenotype? 2006;4(4):294\u2013309.","DOI":"10.3121\/cmr.4.4.294"},{"key":"1565_CR71","doi-asserted-by":"crossref","unstructured":"Muhaya, Calder, Towler, Shaer, Mclauchlan, Clinical LJ, et al. Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs\u2019 heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). 1998;111(1):123\u20138.","DOI":"10.1046\/j.1365-2249.1998.00428.x"},{"issue":"5","key":"1565_CR72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21(5):331\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1565_CR73","doi-asserted-by":"crossref","unstructured":"Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg HJB, communications br. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. 2004;323(2):630\u20135.","DOI":"10.1016\/j.bbrc.2004.08.145"},{"issue":"9","key":"1565_CR74","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/ijms22094972","volume":"22","author":"K Nagata","year":"2021","unstructured":"Nagata K, Nishiyama C. IL-10 in mast cell-mediated immune responses: anti-inflammatory and proinflammatory roles. Int J Mol Sci. 2021;22(9):4972.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1565_CR75","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/intimm\/10.6.807","volume":"10","author":"L Rizzo","year":"1998","unstructured":"Rizzo L, Xu H, Chan C-C, Wiggert B, Caspi RRJli. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol. 1998;10(6):807\u201314. https:\/\/doi.org\/10.1093\/intimm\/10.6.807.","journal-title":"Int Immunol"},{"issue":"12","key":"1565_CR76","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.4049\/jimmunol.177.12.8331","volume":"177","author":"HM Ashour","year":"2006","unstructured":"Ashour HM, Niederkorn JY. \u03b3\u03b4 T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J Immunol. 2006;177(12):8331\u20137. https:\/\/doi.org\/10.4049\/jimmunol.177.12.8331.","journal-title":"J Immunol"},{"key":"1565_CR77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2016.01.006","volume":"88","author":"D Toscano-Tejeida","year":"2016","unstructured":"Toscano-Tejeida D, Ibarra A, Phillips-Farf\u00e1n B, Fuentes-Far\u00edas A, Mel\u00e9ndez-Herrera E. ACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases. Med Hypotheses. 2016;88:38\u201345.","journal-title":"Med Hypotheses"},{"issue":"5","key":"1565_CR78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cytogfr.2015.07.003","volume":"26","author":"S Zundler","year":"2015","unstructured":"Zundler S, Neurath MF. Interleukin-12: functional activities and implications for disease. Cytokine Growth Factor Rev. 2015;26(5):559\u201368.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"1565_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/030.63.2016.1.1","volume":"63","author":"P Behzadi","year":"2016","unstructured":"Behzadi P, Behzadi E, Ranjbar R. IL-12 family cytokines: general characteristics, pathogenic microorganisms, receptors, and signalling pathways. Acta Microbiol Immunol Hung. 2016;63(1):1\u201325.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"16","key":"1565_CR80","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","volume":"13","author":"M Del Vecchio","year":"2007","unstructured":"Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A. Interleukin-12: biological properties and clinical application. Clin Cancer Res. 2007;13(16):4677\u201385. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0776.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1565_CR81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.161.1.122","volume":"161","author":"TK Tarrant","year":"1998","unstructured":"Tarrant TK, Silver PB, Chan C-C, Wiggert B, Caspi RR. Endogenous IL-12 Is required for induction and expression of experimental autoimmune uveitis. J Immunol. 1998;161(1):122\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"1565_CR82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KH Mills","year":"2023","unstructured":"Mills KH. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1565_CR83","doi-asserted-by":"crossref","first-page":"479","DOI":"10.31557\/apjcb.2024.9.4.479-486","volume":"9","author":"N Khaje","year":"2024","unstructured":"Khaje N, Salehan F, Shakiba D, Shabestari AM, Shoarishoar SS. In vitro assessment of paclitaxel-loaded niosome nanoparticles and their cytotoxic effects on the ovarian cancer cell line A2780CP. Asian Pacific J Cancer Biol. 2024;9(4):479\u201386.","journal-title":"Asian Pacific J Cancer Biol"},{"key":"1565_CR84","doi-asserted-by":"crossref","unstructured":"Jin W, Dong CJEm, Infections. IL-17 cytokines in immunity and inflammation. 2013;2(1):1\u20135.","DOI":"10.1038\/emi.2013.58"},{"issue":"2","key":"1565_CR85","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cyto.2013.03.014","volume":"62","author":"X Song","year":"2013","unstructured":"Song X, Qian Y. The activation and regulation of IL-17 receptor mediated signaling. Cytokine. 2013;62(2):175\u201382. https:\/\/doi.org\/10.1016\/j.cyto.2013.03.014.","journal-title":"Cytokine"},{"issue":"1","key":"1565_CR86","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cyto.2014.12.017","volume":"74","author":"D Sun","year":"2015","unstructured":"Sun D, Liang D, Kaplan HJ, Shao H. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine. 2015;74(1):76\u201380. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.017.","journal-title":"Cytokine"},{"issue":"4","key":"1565_CR87","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1084\/jem.20071258","volume":"205","author":"D Luger","year":"2008","unstructured":"Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205(4):799\u2013810. https:\/\/doi.org\/10.1084\/jem.20071258.","journal-title":"J Exp Med"},{"issue":"6","key":"1565_CR88","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi A, Yu C-R, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1. Nat Med. 2007;13(6):711\u20138.","journal-title":"Nat Med"},{"issue":"3","key":"1565_CR89","volume":"6","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang P, Li F, Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS ONE. 2011;6(3): e18139.","journal-title":"PLoS ONE"},{"issue":"2","key":"1565_CR90","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","volume":"20","author":"T Yoshimura","year":"2008","unstructured":"Yoshimura T, Sonoda K-H, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, et al. Differential roles for IFN-\u03b3 and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20(2):209\u201314.","journal-title":"Int Immunol"},{"issue":"11","key":"1565_CR91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049008","volume":"7","author":"U Kaufmann","year":"2012","unstructured":"Kaufmann U, Diedrichs-M\u00f6hring M, Wildner G. Dynamics of intraocular IFN-\u03b3, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis. PLoS ONE. 2012;7(11): e49008.","journal-title":"PLoS ONE"},{"issue":"9","key":"1565_CR92","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/0301-4738.194339","volume":"64","author":"MCE Guedes","year":"2016","unstructured":"Guedes MCE, Borrego LM, Proen\u00e7a RD. Roles of interleukin-17 in uveitis. Indian J Ophthalmol. 2016;64(9):628\u201334.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1565_CR93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","volume":"139","author":"AMA El-Asrar","year":"2011","unstructured":"El-Asrar AMA, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol. 2011;139(2):177\u201384.","journal-title":"Clin Immunol"},{"issue":"6","key":"1565_CR94","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/09273948.2013.815786","volume":"21","author":"S Jawad","year":"2013","unstructured":"Jawad S, Liu B, Agron E, Nussenblatt RB, Sen HN. Elevated serum levels of interleukin-17A in uveitis patients. Ocul Immunol Inflamm. 2013;21(6):434\u20139.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"1565_CR95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajo.2011.01.031","volume":"152","author":"JJW Kuiper","year":"2011","unstructured":"Kuiper JJW, Mutis T, de Jager W, de Groot-Mijnes JDF, Rothova A. Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29\u2013associated birdshot chorioretinopathy. Am J Ophthalmol. 2011;152(2):177-182.e1. https:\/\/doi.org\/10.1016\/j.ajo.2011.01.031.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1565_CR96","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/bjophthalmol-2014-306106","volume":"99","author":"A Mucientes","year":"2015","unstructured":"Mucientes A, M\u00e1rquez A, Cordero-Coma M, Mart\u00edn-Villa JM, Gorro\u00f1o-Echebarr\u00eda MB, Blanco R, et al. Specific association of IL17A genetic variants with panuveitis. Br J Ophthalmol. 2015;99(4):566\u201370.","journal-title":"Br J Ophthalmol"},{"key":"1565_CR97","doi-asserted-by":"crossref","unstructured":"Taylor MW, Taylor MW. Interferons. Viruses and man: a history of interactions. 2014:101-19.","DOI":"10.1007\/978-3-319-07758-1_7"},{"key":"1565_CR98","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.genrep.2024.101901","volume":"35","author":"M Salehi","year":"2024","unstructured":"Salehi M, Kamali MJ, Ashuori Z, Ghadimi F, Shafiee M, Babaei S, Moghadam AAS. Functional significance of tRNA-derived fragments in sustained proliferation of tumor cells. Gene Rep. 2024;35:101901. https:\/\/doi.org\/10.1016\/j.genrep.2024.101901.","journal-title":"Gene Rep"},{"issue":"1","key":"1565_CR99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09273948.2017.1298822","volume":"27","author":"X Liu","year":"2019","unstructured":"Liu X, Diedrichs-M\u00f6hring M, Wildner G. The role of IFN-alpha in experimental and clinical uveitis. Ocul Immunol Inflamm. 2019;27(1):23\u201333.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"1565_CR100","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/rheumatology\/keq330","volume":"50","author":"X Liu","year":"2011","unstructured":"Liu X, Yang P, Wang C, Li F, Kijlstra A. IFN- blocks IL-17 production by peripheral blood mononuclear cells in Behcet\u2019s disease. Rheumatology. 2011;50(2):293\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keq330.","journal-title":"Rheumatology"},{"issue":"10","key":"1565_CR101","doi-asserted-by":"publisher","first-page":"e48566","DOI":"10.1371\/journal.pone.0048566","volume":"7","author":"Y Yang","year":"2012","unstructured":"Yang Y, Liping D, Sun M, Kijlstra A, Yang P. IFN-\u03b2 inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis. PLoS ONE. 2012;7(10):e48566. https:\/\/doi.org\/10.1371\/journal.pone.0048566.","journal-title":"PLoS ONE"},{"key":"1565_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.831084","author":"H Shao","year":"2022","unstructured":"Shao H, Kaplan HJ, Sun D. Bidirectional effect of IFN-\u03b3 on Th17 responses in experimental autoimmune uveitis. Front Ophthalmol. 2022. https:\/\/doi.org\/10.3389\/fopht.2022.831084.","journal-title":"Front Ophthalmol"},{"issue":"7","key":"1565_CR103","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","volume":"12","author":"D Saadoun","year":"2013","unstructured":"Saadoun D, Bodaghi B, Bienvenu B, Wechsler B, Sene D, Trad S, et al. Biotherapies in inflammatory ocular disorders: interferons, immunoglobulins, monoclonal antibodies. Autoimmun Rev. 2013;12(7):774\u201383.","journal-title":"Autoimmun Rev"},{"key":"1565_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6693542","volume":"2021","author":"K Guo","year":"2021","unstructured":"Guo K, Zhang X. Cytokines that modulate the differentiation of Th17 cells in autoimmune uveitis. J Immunol Res. 2021;2021:1\u201319. https:\/\/doi.org\/10.1155\/2021\/6693542.","journal-title":"J Immunol Res"},{"issue":"5","key":"1565_CR105","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"D-i Jang","year":"2021","unstructured":"Jang D-i, Lee A-H, Shin H-Y, Song H-R, Park J-H, Kang T-B, et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1565_CR106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/09273948.2012.723109","volume":"20","author":"H Ghasemi","year":"2012","unstructured":"Ghasemi H, Ghazanfari T, Yaraee R, Owlia P, Hassan ZM, Faghihzadeh S. Roles of IL-10 in ocular inflammations: a review. Ocul Immunol Inflamm. 2012;20(6):406\u201318.","journal-title":"Ocul Immunol Inflamm"},{"issue":"13","key":"1565_CR107","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-12-3946","volume":"73","author":"M Yu","year":"2013","unstructured":"Yu M, Zhou X, Niu L, Lin G, Huang J, Zhou W, et al. Targeting transmembrane TNF-\u03b1 suppresses breast cancer growth. Can Res. 2013;73(13):4061\u201374.","journal-title":"Can Res"},{"key":"1565_CR108","doi-asserted-by":"crossref","unstructured":"Jiang Q, Li Z, Tao T, Duan R, Wang X, Su WJFip. TNF-\u03b1 in uveitis: from bench to clinic. 2021; 12: 740057.","DOI":"10.3389\/fphar.2021.740057"},{"issue":"2","key":"1565_CR109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/biom14020169","volume":"14","author":"S Wang","year":"2024","unstructured":"Wang S, Kahale F, Naderi A, Surico PL, Yin J, Dohlman T, et al. Therapeutic effects of stimulating the melanocortin pathway in regulating ocular inflammation and cell death. Biomolecules. 2024;14(2):169.","journal-title":"Biomolecules"},{"issue":"1","key":"1565_CR110","first-page":"52","volume":"69","author":"J Sanceau","year":"1990","unstructured":"Sanceau J, Falcoff R, Beranger F, Carter D, Wietzerbin J. Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha. Immunology. 1990;69(1):52.","journal-title":"Immunology"},{"issue":"7","key":"1565_CR111","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cellsig.2010.01.010","volume":"22","author":"KM Park","year":"2010","unstructured":"Park KM, Bowers WJ. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal. 2010;22(7):977\u201383.","journal-title":"Cell Signal"},{"issue":"6","key":"1565_CR112","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","volume":"60","author":"M Cordero-Coma","year":"2015","unstructured":"Cordero-Coma M, Sobrin L. Anti\u2013tumor necrosis factor-\u03b1 therapy in uveitis. Survey Ophthalmol. 2015;60(6):575\u201389. https:\/\/doi.org\/10.1016\/j.survophthal.2015.06.004.","journal-title":"Survey Ophthalmol"},{"key":"1565_CR113","doi-asserted-by":"crossref","unstructured":"Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki MJAr, et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet\u2019s disease. 2012;14(3):1-12","DOI":"10.1186\/ar3824"},{"issue":"5","key":"1565_CR114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","volume":"33","author":"M Santos Lacomba","year":"2001","unstructured":"Santos Lacomba M, Marcos Mart\u00edn C, Gallardo Galera JM, G\u00f3mez Vidal MA, Collantes Est\u00e9vez E, Ram\u00edrez Chamond R, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33(5):251\u20135.","journal-title":"Ophthalmic Res"},{"issue":"2","key":"1565_CR115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D. Tumor necrosis factor \u03b1 blockade with infliximab for refractory uveitis and scleritis. Ophthalmology. 2004;111(2):352\u20136.","journal-title":"Ophthalmology"},{"key":"1565_CR116","doi-asserted-by":"crossref","first-page":"1412930","DOI":"10.3389\/fopht.2024.1412930","volume":"4","author":"K Chauhan","year":"2024","unstructured":"Chauhan K, Tyagi M. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond. Front Ophthalmol. 2024;4:1412930.","journal-title":"Front Ophthalmol."},{"issue":"3","key":"1565_CR117","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/09273948.2016.1236968","volume":"26","author":"A-E Mercier","year":"2018","unstructured":"Mercier A-E, Ribeiro E, Korobelnik J-F, Delyfer M-N, Rougier M-B. Efficacy of anti-TNF-\u03b1 therapy for the treatment of non-infectious uveitis: a retrospective study of 21 patients. Ocul Immunol Inflamm. 2018;26(3):477\u201384.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"1565_CR118","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","volume":"53","author":"V Calvo-R\u00edo","year":"2014","unstructured":"Calvo-R\u00edo V, Blanco R, Beltr\u00e1n E, S\u00e1nchez-Burs\u00f3n J, Mesquida M, Adan A, et al. Anti-TNF-\u03b1 therapy in patients with refractory uveitis due to Beh\u00e7et\u2019s disease: a 1-year follow-up study of 124 patients. Rheumatology. 2014;53(12):2223\u201331.","journal-title":"Rheumatology"},{"issue":"6","key":"1565_CR119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10965-024-04000-9","volume":"31","author":"E Abbasi","year":"2024","unstructured":"Abbasi E, Ghamkhari A, Ghorbani M, Salati MA, Abbasi F. Facile construction of pH-responsive nanocarrier based on host\u2013guest interactions chemistry for triggered drug delivery. J Polym Res. 2024;31(6):182.","journal-title":"J Polym Res"},{"issue":"12","key":"1565_CR120","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","volume":"30","author":"D Wendling","year":"2014","unstructured":"Wendling D, Joshi A, Reilly P, Jalundhwala YJ, Mittal M, Bao Y. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database. Curr Med Res Opin. 2014;30(12):2515\u201321.","journal-title":"Curr Med Res Opin"},{"key":"1565_CR121","doi-asserted-by":"crossref","unstructured":"Wendling D, Paccou J, Berthelot J-M, Flipo R-M, Guillaume-Czitrom S, Prati C, et al., editors. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Seminars in arthritis and rheumatism; 2011: Elsevier.","DOI":"10.1016\/j.semarthrit.2011.05.005"},{"issue":"9","key":"1565_CR122","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","volume":"76","author":"E Lie","year":"2017","unstructured":"Lie E, Lindstr\u00f6m U, Zverkova-Sandstr\u00f6m T, Olsen IC, Forsblad-d\u2019Elia H, Askling J, et al. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis. 2017;76(9):1515\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1565_CR123","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s100670200125","volume":"21","author":"S Pay","year":"2002","unstructured":"Pay S, Erdem H, Serdar M, Din\u00e7 A, \u015eim\u015fek \u0130, Turan M. Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Beh\u00e7et\u2019s disease and familial Mediterranean fever? Clin Rheumatol. 2002;21:511\u20135.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1565_CR124","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jop.2010.0079","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Yoneda M, Takeyama M, Sugita I, Tsunekawa H, Yamada H, et al. Effect of infliximab on tumor necrosis factor-alpha-induced alterations in retinal microvascular endothelial cells and retinal pigment epithelial cells. J Ocul Pharmacol Ther. 2010;26(6):549\u201356.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"1565_CR125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cytogfr.2013.11.001","volume":"25","author":"P Biancheri","year":"2014","unstructured":"Biancheri P, Giuffrida P, Docena GH, MacDonald TT, Corazza GR, Di Sabatino A. The role of transforming growth factor (TGF)-\u03b2 in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev. 2014;25(1):45\u201355.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"1565_CR126","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.4049\/jimmunol.2400353","volume":"213","author":"S Mamand","year":"2024","unstructured":"Mamand S, Liu H, Kashem M, Martin A. Suppression of class switch recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-\u03b2 signaling. J Immunol. 2024;213(12):1739\u201345. https:\/\/doi.org\/10.4049\/jimmunol.2400353.","journal-title":"J Immunol"},{"issue":"3","key":"1565_CR127","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.00024.2023","volume":"104","author":"S-N Yang","year":"2024","unstructured":"Yang S-N, Shi Y, Berggren P-O. The anterior chamber of the eye technology and its anatomical, optical, and immunological bases. Physiol Rev. 2024;104(3):881\u2013929.","journal-title":"Physiol Rev"},{"issue":"1","key":"1565_CR128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12886-024-03691-4","volume":"24","author":"J Xiao","year":"2024","unstructured":"Xiao J, Zhao C, Cheng G, Song H, Zhang Y, Zhang M. Multiple cytokine analysis of aqueous humor in uveitis with or without secondary glaucoma. BMC Ophthalmol. 2024;24(1):451.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"1565_CR129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/eji.201546043","volume":"46","author":"S Kobayashi","year":"2016","unstructured":"Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-\u03b2 induces the differentiation of human CXCL13-producing CD4+ T cells. Eur J Immunol. 2016;46(2):360\u201371.","journal-title":"Eur J Immunol"},{"issue":"9","key":"1565_CR130","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Wan YYJC. Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology. Cell Mol Immunol. 2023;20(9):1002\u201322.","journal-title":"Cell Mol Immunol"},{"issue":"3 Suppl 72","key":"1565_CR131","first-page":"S35","volume":"30","author":"J Shimizu","year":"2012","unstructured":"Shimizu J, Izumi T, Arimitsu N, Fujiwara N, Ueda Y, Wakisaka S, et al. Skewed TGF\u03b2\/Smad signalling pathway in T cells in patients with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S35\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1565_CR132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09273948.2016.1196711","volume":"26","author":"RK Sharma","year":"2018","unstructured":"Sharma RK, Gupta A, Kamal S, Bansal R, Singh N, Sharma K, et al. Role of regulatory T cells in tubercular uveitis. Ocul Immunol Inflamm. 2018;26(1):27\u201336.","journal-title":"Ocul Immunol Inflamm"},{"key":"1565_CR133","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00417-019-04255-9","volume":"257","author":"B Matta","year":"2019","unstructured":"Matta B, Bora PS, Neuhouser AJ, Bora NS. Inhibitory role of transforming growth factor \u03b22 in experimental autoimmune anterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2019;257:953\u201360.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"1565_CR134","first-page":"659","volume":"8","author":"LF Yuan","year":"2015","unstructured":"Yuan LF, Li GD, Ren XJ, Nian H, Li XR, Zhang XM. Rapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1\/Th2\/Th17 cells and upregulating CD4+CD25+ Foxp3 regulatory T cells. Int J Ophthalmol. 2015;8(4):659\u201364.","journal-title":"Int J Ophthalmol"},{"key":"1565_CR135","doi-asserted-by":"crossref","unstructured":"Pichi F, Carrai P, Srivastava SK, Lowder CY, Nucci P, Neri PJIo. Genetic of uveitis. 2016;36:419-33","DOI":"10.1007\/s10792-015-0136-9"},{"key":"1565_CR136","doi-asserted-by":"crossref","unstructured":"Allen SJ, Crown SE, Handel TMJARI. Chemokine: receptor structure, interactions, and antagonism. 2007;25(1):787\u2013820.","DOI":"10.1146\/annurev.immunol.24.021605.090529"},{"issue":"4","key":"1565_CR137","doi-asserted-by":"crossref","first-page":"2302429","DOI":"10.1002\/adhm.202302429","volume":"13","author":"K Young","year":"2024","unstructured":"Young K, Yamane S, GharehTapeh EA, Kasamatsu S, Ihara H, Hasegawa U. Manganese porphyrin-containing polymeric micelles: a novel approach for intracellular catalytic formation of per\/polysulfide species from a hydrogen sulfide donor. Adv Healthcare Mater. 2024;13(4):2302429.","journal-title":"Adv Healthcare Mater"},{"key":"1565_CR138","doi-asserted-by":"crossref","unstructured":"El-Asrar AMA, Berghmans N, Al-Obeidan SA, Mousa A, Opdenakker G, Van Damme J, et al. The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. 2016; 57(11):4606\u201313.","DOI":"10.1167\/iovs.16-19758"},{"issue":"1","key":"1565_CR139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12348-022-00323-0","volume":"13","author":"W Rojas-Carabali","year":"2023","unstructured":"Rojas-Carabali W, Mej\u00eda-Salgado G, Cifuentes-Gonz\u00e1lez C, Villabona-Mart\u00ednez V, Barraquer-L\u00f3pez ND, Vald\u00e9s-Arias D, et al. Clinical relationship between dry eye disease and uveitis: a scoping review. J Ophthal Inflam Infect. 2023;13(1):2.","journal-title":"J. Ophthal. Inflam. Infect"},{"issue":"443","key":"1565_CR140","volume":"11","author":"I-M Fang","year":"2005","unstructured":"Fang I-M, Lin C-P, Yang C-M, Chen M-S, Yang C-H. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Mol Vis. 2005;11(443): e51.","journal-title":"Mol Vis"},{"issue":"4","key":"1565_CR141","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1167\/iovs.02-0233","volume":"44","author":"MD Silverman","year":"2003","unstructured":"Silverman MD, Zamora DO, Pan Y, Texeira PV, Baek S-H, Planck SR, et al. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest Ophthalmol Vis Sci. 2003;44(4):1608\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1565_CR142","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1111\/aos.13292","volume":"95","author":"E Carre\u00f1o","year":"2017","unstructured":"Carre\u00f1o E, Portero A, Herreras JM, Garc\u00eda-V\u00e1zquez C, Whitcup SM, Stern ME, et al. Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmol. 2017;95(5):e405\u201314.","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"1565_CR143","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1167\/iovs.05-0444","volume":"46","author":"SJ Curnow","year":"2005","unstructured":"Curnow SJ, Falciani F, Durrani OM, Cheung CM, Ross EJ, Wloka K, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci. 2005;46(11):4251\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1565_CR144","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2018.10.004","volume":"44","author":"R Janssens","year":"2018","unstructured":"Janssens R, Struyf S, Proost P. Pathological roles of the homeostatic chemokine CXCL12. Cytokine Growth Factor Rev. 2018;44:51\u201368.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1565_CR145","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64126-0","volume":"158","author":"C Agostini","year":"2001","unstructured":"Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, Loy M, et al. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol. 2001;158(5):1703\u201311.","journal-title":"Am J Pathol"},{"issue":"12","key":"1565_CR146","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1076\/ceyr.16.12.1202.5034","volume":"16","author":"MJ Verma","year":"1997","unstructured":"Verma MJ, Lloyd A, Rager H, Strieter RR, Kunkel S, Taub D, et al. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16(12):1202\u20138.","journal-title":"Curr Eye Res"},{"issue":"4","key":"1565_CR147","volume":"4","author":"JB Lin","year":"2024","unstructured":"Lin JB, Pepple KL, Concepcion C, Korshunova Y, Paley MA, Paley GL, et al. Aqueous macrophages contribute to conserved CCL2 and CXCL10 gradients in uveitis. Ophthalmol Sci. 2024;4(4): 100453.","journal-title":"Ophthalmol Sci"},{"key":"1565_CR148","first-page":"3","volume":"10","author":"NA Rao","year":"2021","unstructured":"Rao NA. Editorial on uveitis and intraocular inflammations. LWW. 2021;10:3\u20134.","journal-title":"LWW"},{"key":"1565_CR149","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/bs.pmbts.2015.04.009","volume":"134","author":"S Hou","year":"2015","unstructured":"Hou S, Kijlstra A, Yang P. Molecular genetic advances in uveitis. Prog Mol Biol Transl Sci. 2015;134:283\u201398.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"1565_CR150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12886-024-03575-7","volume":"24","author":"AC Brown","year":"2024","unstructured":"Brown AC, Quiroz J, Parikh DA, Li Y, Ritzer L, Rosen R, et al. Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis. BMC Ophthalmol. 2024;24(1):312.","journal-title":"BMC Ophthalmol"},{"key":"1565_CR151","doi-asserted-by":"crossref","unstructured":"Alimi N, Hamidi Madani Z, Saranjam R, Shoarishoar SS, Massoudifar A, Haghighi Z, et al. Investigating Body Dysmorphic Disorder in Pregnant Mothers Requesting Cesarean Section. Journal of Obstetrics, Gynecology and Cancer Research. 2024.","DOI":"10.24200\/jogcr.10.11.825"},{"key":"1565_CR152","doi-asserted-by":"crossref","unstructured":"Rodrigues Alves N, Bar\u00e3o C, Mota C, Costa L, Proen\u00e7a RP. Immune recovery uveitis: a focus review. Graefe\u2019s Archive for Clinical and Experimental Ophthalmology. 2024:1\u201310.","DOI":"10.1007\/s00417-024-06415-y"},{"key":"1565_CR153","doi-asserted-by":"crossref","unstructured":"Wu M, Fletcher EL, Chinnery HR, Downie LE, Mueller SN. Redefining our vision: an updated guide to the ocular immune system. Nature Reviews Immunology. 2024:1\u201316.","DOI":"10.1038\/s41577-024-01064-y"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01565-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:45:02Z","timestamp":1764917102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01565-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01565-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"49"}}